A citation-based method for searching scientific literature

Rui-Xue Huang, Ping-Kun Zhou. Signal Transduct Target Ther 2020
Times Cited: 87







List of co-cited articles
616 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The DNA-damage response in human biology and disease.
Stephen P Jackson, Jiri Bartek. Nature 2009
14

ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response.
Andrew N Blackford, Stephen P Jackson. Mol Cell 2017
660
12

State-of-the-art strategies for targeting the DNA damage response in cancer.
Patrick G Pilié, Chad Tang, Gordon B Mills, Timothy A Yap. Nat Rev Clin Oncol 2019
315
9

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
9

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.
Stephen T Durant, Li Zheng, Yingchun Wang, Kan Chen, Lingli Zhang, Tianwei Zhang, Zhenfan Yang, Lucy Riches, Antonio G Trinidad, Jacqueline H L Fok,[...]. Sci Adv 2018
80
8

Altering DNA Repair to Improve Radiation Therapy: Specific and Multiple Pathway Targeting.
Julian Biau, Emmanuel Chautard, Pierre Verrelle, Marie Dutreix. Front Oncol 2019
39
17

The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.
Holly E Barker, James T E Paget, Aadil A Khan, Kevin J Harrington. Nat Rev Cancer 2015
811
8

ATM Mutations in Cancer: Therapeutic Implications.
Michael Choi, Thomas Kipps, Razelle Kurzrock. Mol Cancer Ther 2016
200
6

Non-homologous DNA end joining and alternative pathways to double-strand break repair.
Howard H Y Chang, Nicholas R Pannunzio, Noritaka Adachi, Michael R Lieber. Nat Rev Mol Cell Biol 2017
564
6

AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity.
Jacqueline H L Fok, Antonio Ramos-Montoya, Mercedes Vazquez-Chantada, Paul W G Wijnhoven, Valeria Follia, Neil James, Paul M Farrington, Ankur Karmokar, Sophie E Willis, Jonathan Cairns,[...]. Nat Commun 2019
61
9

DNA damage sensing by the ATM and ATR kinases.
Alexandre Maréchal, Lee Zou. Cold Spring Harb Perspect Biol 2013
631
6

DNA double-strand break repair-pathway choice in somatic mammalian cells.
Ralph Scully, Arvind Panday, Rajula Elango, Nicholas A Willis. Nat Rev Mol Cell Biol 2019
303
6


Roles of Chk1 in cell biology and cancer therapy.
Youwei Zhang, Tony Hunter. Int J Cancer 2014
221
5


DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139.
E P Rogakou, D R Pilch, A H Orr, V S Ivanova, W M Bonner. J Biol Chem 1998
5

The DNA damage response: making it safe to play with knives.
Alberto Ciccia, Stephen J Elledge. Mol Cell 2010
5


Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
5

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Shideng Bao, Qiulian Wu, Roger E McLendon, Yueling Hao, Qing Shi, Anita B Hjelmeland, Mark W Dewhirst, Darell D Bigner, Jeremy N Rich. Nature 2006
5


Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
E Fokas, R Prevo, J R Pollard, P M Reaper, P A Charlton, B Cornelissen, K A Vallis, E M Hammond, M M Olcina, W Gillies McKenna,[...]. Cell Death Dis 2012
213
5


PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors.
Leslie A Parsels, David Karnak, Joshua D Parsels, Qiang Zhang, Jonathan Vélez-Padilla, Zachery R Reichert, Daniel R Wahl, Jonathan Maybaum, Mark J O'Connor, Theodore S Lawrence,[...]. Mol Cancer Res 2018
63
6

Therapeutic opportunities within the DNA damage response.
Laurence H Pearl, Amanda C Schierz, Simon E Ward, Bissan Al-Lazikani, Frances M G Pearl. Nat Rev Cancer 2015
280
4

Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells.
Rebecca L Lloyd, Paul W G Wijnhoven, Antonio Ramos-Montoya, Zena Wilson, Giuditta Illuzzi, Katarzyna Falenta, Gemma N Jones, Neil James, Christophe D Chabbert, Jonathan Stott,[...]. Oncogene 2020
33
12

Nonhomologous DNA end-joining for repair of DNA double-strand breaks.
Nicholas R Pannunzio, Go Watanabe, Michael R Lieber. J Biol Chem 2018
202
4

Targeting DNA Repair in Cancer: Beyond PARP Inhibitors.
Jessica S Brown, Brent O'Carrigan, Stephen P Jackson, Timothy A Yap. Cancer Discov 2017
267
4

The DNA damage response and cancer therapy.
Christopher J Lord, Alan Ashworth. Nature 2012
943
4

Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
Theo A Knijnenburg, Linghua Wang, Michael T Zimmermann, Nyasha Chambwe, Galen F Gao, Andrew D Cherniack, Huihui Fan, Hui Shen, Gregory P Way, Casey S Greene,[...]. Cell Rep 2018
315
4

The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.
Frank P Vendetti, Alan Lau, Sandra Schamus, Thomas P Conrads, Mark J O'Connor, Christopher J Bakkenist. Oncotarget 2015
125
4

Beyond DNA repair: DNA-PK function in cancer.
Jonathan F Goodwin, Karen E Knudsen. Cancer Discov 2014
130
4


The multifaceted roles of PARP1 in DNA repair and chromatin remodelling.
Arnab Ray Chaudhuri, André Nussenzweig. Nat Rev Mol Cell Biol 2017
464
4


RAD52 Functions in Homologous Recombination and Its Importance on Genomic Integrity Maintenance and Cancer Therapy.
Augusto Nogueira, Mara Fernandes, Raquel Catarino, Rui Medeiros. Cancers (Basel) 2019
23
17

Mitotic catastrophe: a mechanism for avoiding genomic instability.
Ilio Vitale, Lorenzo Galluzzi, Maria Castedo, Guido Kroemer. Nat Rev Mol Cell Biol 2011
505
4

The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and as Orthotopic Xenografts.
Cindy R Timme, Barbara H Rath, John W O'Neill, Kevin Camphausen, Philip J Tofilon. Mol Cancer Ther 2018
41
9

Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy.
Victoria Dunne, Mihaela Ghita, Donna M Small, Caroline B M Coffey, Sinead Weldon, Clifford C Taggart, Sarah O Osman, Conor K McGarry, Kevin M Prise, Gerard G Hanna,[...]. Radiother Oncol 2017
16
25

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
Scott J Antonia, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki H Lee, Maike de Wit,[...]. N Engl J Med 2018
4

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Eric Pujade-Lauraine, Jonathan A Ledermann, Frédéric Selle, Val Gebski, Richard T Penson, Amit M Oza, Jacob Korach, Tomasz Huzarski, Andrés Poveda, Sandro Pignata,[...]. Lancet Oncol 2017
752
4

Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer.
Sana D Karam, Krishna Reddy, Patrick J Blatchford, Tim Waxweiler, Alicia M DeLouize, Ayman Oweida, Hilary Somerset, Carrie Marshall, Christian Young, Kurtis D Davies,[...]. Clin Cancer Res 2018
34
11

Clustered DNA Double-Strand Breaks: Biological Effects and Relevance to Cancer Radiotherapy.
Jac A Nickoloff, Neelam Sharma, Lynn Taylor. Genes (Basel) 2020
48
8

Radiation-induced clustered DNA lesions: Repair and mutagenesis.
Evelyne Sage, Naoya Shikazono. Free Radic Biol Med 2017
109
4

Stress-induced DNA damage biomarkers: applications and limitations.
Zacharenia Nikitaki, Christine E Hellweg, Alexandros G Georgakilas, Jean-Luc Ravanat. Front Chem 2015
74
5

Ionizing Radiation and Complex DNA Damage: From Prediction to Detection Challenges and Biological Significance.
Ifigeneia V Mavragani, Zacharenia Nikitaki, Spyridon A Kalospyros, Alexandros G Georgakilas. Cancers (Basel) 2019
46
8

DNA repair, genome stability and cancer: a historical perspective.
Penny A Jeggo, Laurence H Pearl, Antony M Carr. Nat Rev Cancer 2016
322
4

Cancer and radiation therapy: current advances and future directions.
Rajamanickam Baskar, Kuo Ann Lee, Richard Yeo, Kheng-Wei Yeoh. Int J Med Sci 2012
631
4

Immunologic correlates of the abscopal effect in a patient with melanoma.
Michael A Postow, Margaret K Callahan, Christopher A Barker, Yoshiya Yamada, Jianda Yuan, Shigehisa Kitano, Zhenyu Mu, Teresa Rasalan, Matthew Adamow, Erika Ritter,[...]. N Engl J Med 2012
4

Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death.
Encouse B Golden, Derek Frances, Ilenia Pellicciotta, Sandra Demaria, Mary Helen Barcellos-Hoff, Silvia C Formenti. Oncoimmunology 2014
267
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.